COVID-19, glomerulonefritis ANCA y anti-membrana basal glomerular. Caso clínico
Palabras clave:
Antibodies, Antineutrophil Cytoplasmic, Anti-Glomerular Basement Membrane Disease, Covid-19, Glomerulonephritis, PlasmapheresisResumen
Renal involvement in COVID-19 infection is varied and worsens its outcome and prognosis. However, the association of COVID infection with glomerulonephritis is exceptional. We report a 46-year-old woman with COVID-19 who had an acute kidney injury and ANCA associated glomerulonephritis two weeks after the onset of the disease. The kidney biopsy showed a crescentic glomerulonephritis and the presence of anti-glomerular basement membrane antibodies (GBM-Abs). She was treated with steroids and oral cyclophosphamide with good response without requiring plasmapheresis. Plasma anti GBM-Abs were negative. This case suggests that the presence of anti-GBM-Abs in the kidney, was temporally related to COVID-19 pulmonary damage. The absence of plasma antibodies is probably due to transient production and glomerular adsorption, but with unknown pathogenic role.Descargas
Publicado
2022-09-12
Cómo citar
Briones, E., Méndez, G. P., Laguna, J., & Vargas, M. (2022). COVID-19, glomerulonefritis ANCA y anti-membrana basal glomerular. Caso clínico. Revista Médica De Chile, 150(6). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/9883
Número
Sección
Reporte de Caso Clínico